Bowen E, Langston J, Fletcher H, Domek J, Ulph F
J Genet Couns. 2024; 34(1):e1903.
PMID: 38666560
PMC: 11735185.
DOI: 10.1002/jgc4.1903.
Khangura S, Potter B, Davies C, Ducharme R, Bota A, Hawken S
BMC Pediatr. 2021; 21(1):296.
PMID: 34210267
PMC: 8247172.
DOI: 10.1186/s12887-021-02751-8.
Remus C, Stanislas A, Bouazza N, Gauthereau V, Polak M, Blanche S
Front Pediatr. 2020; 8:300.
PMID: 32637386
PMC: 7318296.
DOI: 10.3389/fped.2020.00300.
van der Burg S, Oerlemans A
Bioethics. 2018; 32(3):171-183.
PMID: 29442381
PMC: 5838405.
DOI: 10.1111/bioe.12425.
Friedman J, Cornel M, Goldenberg A, Lister K, Senecal K, Vears D
BMC Med Genomics. 2017; 10(1):9.
PMID: 28222731
PMC: 5320805.
DOI: 10.1186/s12920-017-0247-4.
A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.
Bombard Y, Miller F, Barg C, Patton S, Carroll J, Chakraborty P
Genet Med. 2016; 19(4):403-411.
PMID: 27608173
PMC: 5319861.
DOI: 10.1038/gim.2016.125.
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.
Botkin J, Belmont J, Berg J, Berkman B, Bombard Y, Holm I
Am J Hum Genet. 2015; 97(1):6-21.
PMID: 26140447
PMC: 4570999.
DOI: 10.1016/j.ajhg.2015.05.022.
Public views on participating in newborn screening using genome sequencing.
Bombard Y, Miller F, Hayeems R, Barg C, Cressman C, Carroll J
Eur J Hum Genet. 2014; 22(11):1248-54.
PMID: 24549052
PMC: 4200434.
DOI: 10.1038/ejhg.2014.22.
Informing children of their newborn screening carrier result for sickle cell or cystic fibrosis: qualitative study of parents' intentions, views and support needs.
Ulph F, Cullinan T, Qureshi N, Kai J
J Genet Couns. 2013; 23(3):409-20.
PMID: 24306142
DOI: 10.1007/s10897-013-9675-2.
Consulting communities on feedback of genetic findings in international health research: sharing sickle cell disease and carrier information in coastal Kenya.
Marsh V, Kombe F, Fitzpatrick R, Williams T, Parker M, Molyneux S
BMC Med Ethics. 2013; 14:41.
PMID: 24125465
PMC: 4016314.
DOI: 10.1186/1472-6939-14-41.
Effort required to contact primary care providers after newborn screening identifies sickle cell trait.
Christopher S, Collins J, Farrell M
J Natl Med Assoc. 2013; 104(11-12):528-34.
PMID: 23560355
PMC: 3880776.
DOI: 10.1016/s0027-9684(15)30219-4.
Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders.
Bombard Y, Miller F, Hayeems R, Wilson B, Carroll J, Paynter M
Eur J Hum Genet. 2011; 20(5):498-504.
PMID: 22071888
PMC: 3330205.
DOI: 10.1038/ejhg.2011.188.
Genetic screening.
Burke W, Tarini B, Press N, Evans J
Epidemiol Rev. 2011; 33:148-64.
PMID: 21709145
PMC: 3166195.
DOI: 10.1093/epirev/mxr008.
Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.
Bombard Y, Miller F, Hayeems R, Avard D, Knoppers B
Eur J Hum Genet. 2010; 18(7):751-60.
PMID: 20197792
PMC: 2987364.
DOI: 10.1038/ejhg.2010.13.
The expansion of newborn screening: is reproductive benefit an appropriate pursuit?.
Bombard Y, Miller F, Hayeems R, Avard D, Knoppers B, Cornel M
Nat Rev Genet. 2009; 10(10):666-7.
PMID: 19763150
DOI: 10.1038/nrg2666.
Clinical and ethical considerations in managing carrier detection.
Friedman Ross L, Clayton E
Am J Public Health. 2009; 99(8):1348-9.
PMID: 19542030
PMC: 2707475.
DOI: 10.2105/AJPH.2009.161554.
Carrier detection and clinical uncertainty: the case for public health ethics.
Miller F, Hayeems R, Robert J
Am J Public Health. 2009; 99(8):1349-50.
PMID: 19542029
PMC: 2707484.
DOI: 10.2105/AJPH.2009.162008.